Dr. John D. Maraganore

GPTKB entity

Statements (57)
Predicate Object
gptkbp:instanceOf Person
gptkbp:hasAwards Various industry awards
gptkbp:hasCharacter Young scientists
gptkbp:hasCollaborationsWith Various research institutions
gptkbp:hasContribution Drug development
Patient advocacy
Biotech education
Healthcare_advancements
gptkbp:hasEducation gptkb:Harvard_University
gptkbp:hasExperienceIn Venture capital
Corporate strategy
RNAi Therapeutics
gptkbp:hasFieldOfUse Biochemistry
gptkbp:hasFilm RNA-based therapies
Sustainable healthcare
Future of medicine
gptkbp:hasFocusOn Patient-centered care
Innovative therapies
Therapeutic innovation
gptkbp:hasImpactOn Patient care
gptkbp:hasInfluenceOn Biotechnology industry
gptkbp:hasMember Over 20 years
gptkbp:hasNationality American
gptkbp:hasOccupation Biotechnology Executive
gptkbp:hasPartnershipsWith Pharmaceutical companies
gptkbp:hasPublications Numerous scientific articles
gptkbp:hasResearchInterest Genetic medicine
gptkbp:hasRole CEO
Corporate governance
Strategic planning
Business development
Innovation management
gptkbp:hasTheme Conferences and seminars
https://www.w3.org/2000/01/rdf-schema#label Dr. John D. Maraganore
gptkbp:isActiveIn Community outreach
Pharmaceutical industry
Research and development
gptkbp:isAssociatedWith gptkb:Alnylam_Pharmaceuticals
gptkbp:isEngagedIn Public health initiatives
Global health issues
gptkbp:isExpectedTo Colleagues
Industry leaders
gptkbp:isInfluencedBy Healthcare_policy
Biotech_startups
gptkbp:isInvolvedIn Clinical trials
Regulatory affairs
gptkbp:isKnownFor Advancements in RNA interference
Innovative drug solutions
Transformative therapies
gptkbp:isMemberOf Scientific_Advisory_Boards
gptkbp:isPartOf Biotech_community
gptkbp:isPublishedIn Scientific journals
gptkbp:isRecognizedBy Industry peers
gptkbp:isRecognizedFor Scientific contributions
Leadership in biotech
gptkbp:wasEducatedAt gptkb:University_of_California,_Berkeley
gptkbp:worksAt gptkb:Alnylam_Pharmaceuticals